(MedPage Today) — CHICAGO — A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST annual meeting hosted by the…
Source link : https://www.medpagetoday.com/meetingcoverage/chest/118129
Author :
Publish date : 2025-10-24 15:43:00
Copyright for syndicated content belongs to the linked Source.
